CSL

Based in Melbourne, CSL is widely regarded as one of Australia's flagship pharmaceuticals operators. Its scale — about 32k people, around $14B in turnover — translates into genuine strategic weight across Asia Pacific.

Digital reinvention is no longer a marketing line: it is reshaping unit economics across customer acquisition, supply chain and after-sales.

“CSL is, in its category, exactly the kind of compounding regional champion the next decade of capital allocation will reward.”

Capital markets have started to price in the durability of the model, and rating agencies have followed.